Altimmune Draws $10 Million Under Hercules Capital Loan Agreement
Bitget2026/10/29 11:20- Altimmune drew $10 million in Tranche Three on October 27, 2026, under a $125 million loan agreement with Hercules Capital and other lenders.
- Meeting clinical and financial milestones extended the interest-only period and amortization date to June 1, 2028.
- The minimum cash covenant now requires qualified cash equal to at least 60% of outstanding Term Loan Advances principal.
- A 1% tranche facility charge was deducted from funding; the end-of-term charge remains 6.25% of amounts funded.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
After the sharp decline in tech stocks, the White House suddenly canceled the top tech advisor meeting the following day.
The White House has canceled the previously scheduled President’s Council of Advisors on Science and Technology meeting, which was set for Friday and includes prominent tech leaders such as Nvidia CEO Jensen Huang and Meta CEO Mark Zuckerberg. The Department of Energy's meeting page briefly listed November 13 as the new meeting date, but the agency later sent an email retracting this information. Currently, the specific date for rescheduling the meeting remains unclear.
Turtle Creek Asset Management Reports Sale of $347,850 in Jeld-Wen Common Shares
GLOBALFOUNDRIES Director Ganesh Moorthy Reports $93,687.50 Share Acquisition
Crypto prices
More
